{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:29Z","timestamp":1790420189333,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oligosaccharidoses are storage disorders due to enzymatic defects involved in the breakdown of the oligosaccharidic component of glycosylated proteins. The defect cause the accumulation of oligosaccharides (OS) and, depending on the lacking enzyme, results in characteristic profiles which are helpful for the diagnosis. We developed a new tandem mass spectrometry method for the screening of urinary OS which was applied to identify a large panel of storage disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The method was set-up in urine and dried urine spots (DUS). Samples were analysed, without derivatization and using maltoheptaose as internal standard, by UHPLC-MS\/MS with MRM acquisition of target OS transitions, including Glc4, the biomarker of Pompe disease. The chromatographic run was\u2009&lt;\u200930\u00a0min. Samples from patients with known storage disorders were used for clinical validation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The method allowed to confirm the diagnosis of oligosaccharidoses (sialidosis, \u03b1-\/\u03b2-mannosidosis, fucosidosis, aspartylglucosaminuria) and of GM1 and GM2 (Sandhoff type) gangliosidosis, by detecting specific OS profiles. In other storage disorders (mucolipidosis II and III, mucopolysaccharidosis type IVB) the analyisis revealed abnormal OS excretion with non-specific profiles. Besides Pompe disease, the tetrasaccharide Glc4 was increased also in disorders of autophagy (Vici syndrome, Yunis-Varon syndrome, and Danon disease) presenting cardiomuscular involvement with glycogen storage.\u00a0Overall, results showed a clear separation between patients and controls, both in urine and in DUS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This new UHPLC\/MS-MS method, which is suitable for rapid and easy screening of OS in urine and DUS, expands the detection of storage disorders from oligosaccharidoses to other diseases, including the novel category of inherited disorders of autophagy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01662-8","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T12:14:07Z","timestamp":1610194447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A new UHPLC-MS\/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-0486","authenticated-orcid":false,"given":"Michela","family":"Semeraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgay","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Incilay","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Catesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi-Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"1662_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41436-018-0022-8","volume":"21","author":"CR Ferreira","year":"2019","unstructured":"Ferreira CR, van Karnebeek CDM, Vockley J, Blau N. A proposed nosology of inborn errors of metabolism. Genet Med. 2019;21:102\u20136.","journal-title":"Genet Med"},{"key":"1662_CR2","first-page":"1","volume":"2","author":"CR Ferreira","year":"2017","unstructured":"Ferreira CR, Gahl WA. Lysosomal storage diseases. Transl Sci Rare Dis. 2017;2:1\u201371.","journal-title":"Transl Sci Rare Dis"},{"key":"1662_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","volume":"345","author":"SL Ramsay","year":"2005","unstructured":"Ramsay SL, Meikle PJ, Hopwood JJ, Clements PR. Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides. Anal Biochem. 2005;345:30\u201346.","journal-title":"Anal Biochem"},{"key":"1662_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/rcm.7860","volume":"31","author":"M Piraud","year":"2017","unstructured":"Piraud M, Pettazzoni M, Menegaut L, et al. Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses. Rapid Commun Mass Spectrom. 2017;31:951\u201363.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1662_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00441471","volume":"134","author":"AC Sewell","year":"1980","unstructured":"Sewell AC. Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis. Eur J Pediatr. 1980;134:183\u201394.","journal-title":"Eur J Pediatr."},{"key":"1662_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(75)90119-9","volume":"60","author":"R Humbel","year":"1975","unstructured":"Humbel R, Collart M. Oligosaccharides in urine of patients with glycoprotein storage diseases.Rapid detection by thin-layer chromatography. Clin Chim Acta. 1975;60:143.","journal-title":"Clin Chim Acta"},{"key":"1662_CR7","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1093\/clinchem\/39.11.2346","volume":"39","author":"TW Kurczynski","year":"1993","unstructured":"Kurczynski TW, Kendzierski KS, Sewell AC, Kuczynski TW. Urinary oligosaccharides in pregnant or lactating women: pitfall in screening. Clin Chem. 1993;39:2346\u20137.","journal-title":"Clin Chem"},{"key":"1662_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ymgme.2004.07.015","volume":"83","author":"SL Ramsay","year":"2004","unstructured":"Ramsay SL, Maire I, Bindloss C, et al. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab. 2004;83:231\u20138.","journal-title":"Mol Genet Metab"},{"key":"1662_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.aca.2010.11.047","volume":"686","author":"J Sowell","year":"2011","unstructured":"Sowell J, Wood T. Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses. Anal Chim Acta. 2011;686:102\u20136.","journal-title":"Anal Chim Acta"},{"key":"1662_CR10","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00216-012-5968-9","volume":"403","author":"C Bruggink","year":"2012","unstructured":"Bruggink C, Poorthuis BJ, Deelder AM, Wuhrer M. Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry. Anal Bioanal Chem. 2012;403:1671\u201383.","journal-title":"Anal Bioanal Chem"},{"key":"1662_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","volume":"59","author":"B Xia","year":"2013","unstructured":"Xia B, Asif G, Arthur L, et al. Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases. Clin Chem. 2013;59:1357\u201368.","journal-title":"Clin Chem"},{"key":"1662_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-9-19","volume":"9","author":"L Bonesso","year":"2014","unstructured":"Bonesso L, Piraud M, Caruba C, Van Obberghen E, Mengual R, Hinault C. Fast urinary screening of oligosaccharidoses by MALDI-TOF\/TOF mass spectrometry. Orphanet J Rare Dis. 2014;9:19.","journal-title":"Orphanet J Rare Dis"},{"key":"1662_CR13","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1373\/clinchem.2018.289645","volume":"64","author":"R Huang","year":"2018","unstructured":"Huang R, Cathey S, Pollard L, Wood T. UPLC-MS\/MS analysis of urinary free oligosaccharides for lysosomal storage diseases: diagnosis and potential treatment monitoring. Clin Chem. 2018;64:1772\u20139.","journal-title":"Clin Chem"},{"key":"1662_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","volume":"11","author":"SP Young","year":"2009","unstructured":"Young SP, Zhang H, Corzo D, et al. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med. 2009;11:536\u201341.","journal-title":"Genet Med"},{"key":"1662_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","volume":"58","author":"W Sluiter","year":"2012","unstructured":"Sluiter W, van den Bosch J, Goudriaan DA, et al. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases. Clin Chem. 2012;58:1139\u201347.","journal-title":"Clin Chem"},{"key":"1662_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajmg.c.31320","volume":"160","author":"SP Young","year":"2012","unstructured":"Young SP, Piraud M, Goldstein JL, et al. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques. Am J Med Genet C Semin Med Genet. 2012;160:50\u20138.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"1662_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/jpem-2019-0393","volume":"33","author":"E Canbay","year":"2020","unstructured":"Canbay E, Vural M, Kalkan U\u00e7ar S, et al. The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population. J Pediatr Endocrinol Metab. 2020;33:391\u20135.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1662_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0960-8966(94)00089-R","volume":"5","author":"F Dworzak","year":"1995","unstructured":"Dworzak F, Mora M, Borroni C, et al. Generalized lysosomal storage in Yunis-Varon syndrome. Neuromuscul Disord. 1995;5:423\u20138.","journal-title":"Neuromuscul Disord"},{"key":"1662_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/1096-8628(20001113)95:2<157::AID-AJMG12>3.0.CO;2-E","volume":"95","author":"E Walch","year":"2000","unstructured":"Walch E, Schmidt M, Brenner RE, et al. Yunis-Varon syndrome: evidence for a lysosomal storage disease. Am J Med Genet. 2000;95:157\u201360.","journal-title":"Am J Med Genet"},{"key":"1662_CR20","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/ijms21082704","volume":"21","author":"R Mashima","year":"2020","unstructured":"Mashima R, Okuyama T, Ohira M. Biomarkers for lysosomal storage disorders with an emphasis on mass spectrometry. Int J Mol Sci. 2020;21:2704.","journal-title":"Int J Mol Sci"},{"key":"1662_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10545-018-0226-8","volume":"41","author":"\u00c0 Garc\u00eda-Cazorla","year":"2018","unstructured":"Garc\u00eda-Cazorla \u00c0, Saudubray JM. Cellular neurometabolism: a tentative to connect cell biology and metabolism in neurology. J Inherit Metab Dis. 2018;41:1043\u201354.","journal-title":"J Inherit Metab Dis"},{"key":"1662_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176:11\u201342.","journal-title":"Cell"},{"key":"1662_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jimd.12084","volume":"43","author":"J Teinert","year":"2020","unstructured":"Teinert J, Behne R, Wimmer M, Ebrahimi-Fakhari D. Novel insights into the clinical and molecular spectrum of congenital disorders of autophagy. J Inherit Metab Dis. 2020;43:51\u201362.","journal-title":"J Inherit Metab Dis"},{"key":"1662_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ng.2497","volume":"45","author":"T Cullup","year":"2013","unstructured":"Cullup T, Kho AL, Dionisi-Vici C, et al. Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet. 2013;45:83\u20137.","journal-title":"Nat Genet"},{"key":"1662_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13023-016-0399-x","volume":"11","author":"S Byrne","year":"2016","unstructured":"Byrne S, Dionisi-Vici C, Smith L, Gautel M, Jungbluth H. Vici syndrome: a review. Orphanet J Rare Dis. 2016;11:21.","journal-title":"Orphanet J Rare Dis"},{"key":"1662_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ajhg.2013.03.020","volume":"92","author":"PM Campeau","year":"2013","unstructured":"Campeau PM, Lenk GM, Lu JT, et al. Yunis-Varon syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase. Am J Hum Genet. 2013;92:781\u201391.","journal-title":"Am J Hum Genet"},{"key":"1662_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2017.99","volume":"25","author":"MA Lines","year":"2017","unstructured":"Lines MA, Ito Y, Kernohan KD, et al. Yunis-Varon syndrome caused by biallelic VAC14 mutations. Eur J Hum Genet. 2017;25:1049\u201354.","journal-title":"Eur J Hum Genet"},{"key":"1662_CR28","doi-asserted-by":"publisher","first-page":"107217","DOI":"10.1016\/j.carpath.2020.107217","volume":"48","author":"JP Veinot","year":"2020","unstructured":"Veinot JP, Nair V. Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol. 2020;48:107217.","journal-title":"Cardiovasc Pathol"},{"key":"1662_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2019.11.005","volume":"129","author":"BL Farah","year":"2020","unstructured":"Farah BL, Yen PM, Koeberl DD. Links between autophagy and disorders of glycogen metabolism\u2014perspectives on pathogenesis and possible treatments. Mol Genet Metab. 2020;129:3\u201312.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01662-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T12:35:16Z","timestamp":1610195716000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01662-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01662-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The study has been approved by the Etics committee of the Bambino Ges\u00f9 Childrens Hospital (n. 2119_OPBG_2020). All patients (or their guardians) approved of the possible use of their left-over samples for method validation purposes, in agreement with institutional and national legislation. This article does not contain any studies with animal subjects performed by the any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}